Inovio Pharmaceuticals DNA Medicines 2020

Inovio Pharmaceuticals presents its DNA medicine platform with safe, robust immune responses demonstrated in over 2,000 patients. The presentation highlights clinical achievements including the first DNA medicine in Phase 3 trials and pioneering COVID-19 vaccine results showing long-term protection in animal models.